SINGAPORE -- COVID-19 vaccine maker Moderna will expand into Singapore, Hong Kong, Taiwan and Malaysia this year to better serve the Asian market, where its shots continue to be used to battle the coronavirus pandemic.
Taiwan, Malaysia also picked; CEO Bancel eyes vaccine plants in Asia
.jpg?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
Moderna, which developed one of the main COVID-19 vaccines used worldwide, is looking to begin production in Asia. (Source photo by Akira Kodaka and Reuters)
SINGAPORE -- COVID-19 vaccine maker Moderna will expand into Singapore, Hong Kong, Taiwan and Malaysia this year to better serve the Asian market, where its shots continue to be used to battle the coronavirus pandemic.